🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 45258D105
- IPO
- 2/5/2021 · $26.00/share
- ADR Ratio
- 1:1
Business: Immunocore Holdings plc is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease.
Company Contact
- CEO
- Bahija Jallal
- CFO
- Brian Di Donato
- Investor Relations
- ir@immunocore.com